Tisch Cancer Institute, Mount Sinai Hospital — New York, New York

Tisch Cancer Institute, Mount Sinai Hospital is a clinical research site located in New York, New York, United States 10003.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Tisch Cancer Institute, Mount Sinai Hospital has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Metastatic Non-small Cell Lung Cancer.

Sponsors: Thomas Marron.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Tisch Cancer Institute, Mount Sinai Hospital?

Tisch Cancer Institute, Mount Sinai Hospital has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Tisch Cancer Institute, Mount Sinai Hospital conducted?

Tisch Cancer Institute, Mount Sinai Hospital has 1 clinical trials on record, with 1 currently active. Their work covers Metastatic Non-small Cell Lung Cancer.

Is Tisch Cancer Institute, Mount Sinai Hospital accredited by Crixeo Health?

Tisch Cancer Institute, Mount Sinai Hospital has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Tisch Cancer Institute, Mount Sinai Hospital?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.